Jaipal Singh
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$3.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 8, 2025 | NIH | SBIR Phase II Development of a novel disease modifying oral therapy for pulmonary arterial hypertension. | $1.3M | VASCULONICS INC |
| Sep 17, 2024 | NIH | SBIR Phase II Development of a novel disease modifying oral therapy for pulmonary arterial hypertension. | $1.1M | VASCULONICS INC |
| Sep 1, 2020 | NIH | SBIR Phase I A Potential DDAH-Biotherapeutic to Preserve Kidney Function in Cardiac Surgery Patients | $235K | VASCULONICS INC |
| Aug 3, 2020 | NIH | SBIR Phase I A Potential DDAH-Biotherapeutic to Preserve Kidney Function in Cardiac Surgery Patients | $235K | VASCULONICS INC |
| Aug 22, 2019 | NIH | SBIR Phase I A Novel Disease Modifying Therapy for Progression of Pulmonary Arterial Hypertension | $218K | VASCULONICS INC |
Peer ranks
Federal funding#589
Awards as PI#417
Patents#273
Companies
- VASCULONICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.